According to Pentecostal Evangel
, of the Assembly of God, U.S.A., FDA reports that as at April, 2011, 14 women have died and another 612 fallen seriously ill and hospitalized after taking the drug. Several adverse effects have been identified as associated with the use of this abortion drug including the need for blood transfusions in 612 women, infections in 256 women, and cases of ectopic pregnancies in 58 women. Related complications
associated with use of the drug include endometritis
, pelvic inflammatory disease
(PID) and other pelvic infections associated with sepsis.
is a synthetic steroid which acts as progesterone receptor antagonist. It was synthesized by chemist Georges Teutsch in April 1980, and after trials, approval for its use in medical abortion was granted in France on September 23, 1988, amid controversy and anti-abortion protests. The drug was approved for medical abortion in Great Britain on July 1, 1991, and in Sweden, in September, 1992. On May 16, 1994, the company which designed the drug Roussel-Uclaf, donated all rights, "without remuneration," of medical use of mifepristone in the U.S. to the Population Council which licensed the drug to Danco Laboratories.
says Mifepristone is used to cause abortion during early part of pregnancy, up to 7 weeks. It acts by blocking progesterone needed for pregnancy to continue. It is usually used together with another drug called misoprostol, and is not used in cases of ectopic pregnancy because it may cause the pregnancy to rupture leading to serious bleeding.
, of the Family Research Council, says,
"Marketing the abortion drug as simple and painless, such as taking an aspirin, is dangerously misleading to women...Despite the seriousness and intensity of adverse effects related to RU-486, use of this form of abortion is on the rise."